| Thrombolytic therapy is indicated for patients over 75 years of age with st-elevation acute myocardial infarction: antagonist viewpoint. | |
| | |
MedLine Citation:
|
PMID: 14610382 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
From the available data, one cannot conclude whether thrombolytic therapy is beneficial or detrimental in patients older than age 75 years with acute myocardial infarction. Data favor the use of primary percutaneous transluminal coronary angioplasty rather than thrombolysis in eligible patients older than age 75 years with acute myocardial infarction to reduce mortality, recurrent myocardial infarction, stroke, and intracranial hemorrhage. High-risk elderly patients with acute myocardial infarction, such as those with a large anterior myocardial infarction complicated by heart failure and hypotension, those with persistent ischemic pain or marked ST-segment changes, those with hemodynamic instability, and those at high risk for stroke or bleeding complications, should, especially, be treated with percutaneous transluminal coronary angioplasty. |
| | |
Authors:
|
Wilbert S Aronow |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The American journal of geriatric cardiology Volume: 12 ISSN: 1076-7460 ISO Abbreviation: Am J Geriatr Cardiol Publication Date: 2003 Nov-Dec |
Date Detail:
|
Created Date: 2003-11-11 Completed Date: 2004-04-29 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9215283 Medline TA: Am J Geriatr Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 348-50 Citation Subset: IM |
Affiliation:
|
The Cardiology Division, New York Medical College, Valhalla, NY,USA. WSAronow@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angioplasty, Transluminal, Percutaneous Coronary* Fibrinolytic Agents / therapeutic use Humans Myocardial Infarction / drug therapy*, therapy Risk Factors Streptokinase / therapeutic use Thrombolytic Therapy / adverse effects* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thrombolytic therapy is indicated for patients over 75 years of age with st-elevation acute myocardi...
Next Document: Are statins indicated for the primary prevention of coronary heart disease in octogenarians? protago...